Invention Grant
- Patent Title: DNA vaccine for use in pancreatic cancer patients
-
Application No.: US15994766Application Date: 2018-05-31
-
Publication No.: US10293037B2Publication Date: 2019-05-21
- Inventor: Heinz Lubenau
- Applicant: Vaximm AG
- Applicant Address: CH
- Assignee: VAXIMM AG
- Current Assignee: VAXIMM AG
- Current Assignee Address: CH
- Agency: Foley & Lardner LLP
- Agent Antoinette F. Konski
- Priority: EP12004995 20120705
- Main IPC: A61K39/112
- IPC: A61K39/112 ; C07K14/71 ; A61K31/7068 ; A61K39/00 ; C12N1/20 ; C12N1/36 ; C12R1/42
Abstract:
The present invention relates to an attenuated mutant strain of Salmonella comprising a recombinant DNA molecule encoding a VEGF receptor protein. In particular, the present invention relate to the use of said attenuated mutant strain of Salmonella in cancer immunotherapy.
Public/Granted literature
- US20190008936A1 DNA VACCINE FOR USE IN PANCREATIC CANCER PATIENTS Public/Granted day:2019-01-10
Information query
